Down-regulation of vascular endothelial growth factor expression after A(2A) adenosine receptor activation in PC12 pheochromocytoma cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 3, 2000, Pages 779-787

  Olah, Mark E ^a,c   Roudabush, Francine L ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADENOSINE; ANIMALS; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; LYMPHOKINES; PC12 CELLS; PHENETHYLAMINES; RATS; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRIAZINES; TRIAZOLES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034088254     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N and King GL. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487.
2. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K, editors (1997) Current Protocols in Molecular Biology pp 4.10.1-4.10.11, John Wiley & Sons, Inc, New York.
3. Carmeliet P, Ferrara V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W and Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (Lond) 380:435-442.
4. Claffey KP, Wilkison WO and Spiegelman BM (1992) Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 267:16317-16322.
5. Ferrara N and Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
6. Ferrara N (1999) Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56:794-814.
7. 2 dopamine receptors in rat striatum. Mol Brain Res 14:186-195.
8. Finkenzeller G, Technau A and Marmé D (1995) Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Commun 208:432-439.
9. Fischer S, Sharma HS, Karliczek GF and Schaper W (1995) Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Mol Brain Res 28:141-148.
10. Fong GH, Rossant J, Gertsenstein M and Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (Lond) 376:66-70.
11. Gerber H-P, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V and Ferrara N (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidyl 3′-kinase/Akt signal transduction pathway. J Biol Chem 273:30336-30343.
12. Grant MB, Tarnuzzer RW, Caballero S, Ozeck MJ, Davis MI, Spoerri PE, Feoktistov I, Biaggioni I, Shryock JC and Belardinelli L (1999) Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res 85:699-706.
13. Hanahan D and Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
14. Hashimoto E, Kage K, Ogita T, Nakaoka T, Matsuoka R and Kira Y (1994) Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochem Biophys Res Commun 204:318-324.
15. Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, Edwards NA and Oldfield EH (1996) Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. J Clin Invest 98:1400-1408.
16. Holash J, Wiegand SJ and Yancopoulos GD (1999) New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356-5362.
17. Houck KA, Leung DW, Rowland AM, Winer J and Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037.
18. Isner JM and Asahara T (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal vascularization. J Clin Invest 103:1231-1236.
19. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips NS and Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond) 362:841-844.
20. 2A receptor. J Physiol (Lond) 508:95-107.
21. Kobayashi S and Millhorn DE (1999) Stimulation of expression for the adenosine A2A receptor gene by hypoxia in PC12 cells. J Biol Chem 274:20358-20365.
22. Lai H-L, Yang T-H, Messing RO, Ching Y-H, Lin S-C and Chern Y (1997) Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response. J Biol Chem 272:4970-4977.
23. Levy AP, Levy NS, Loscalzo J, Calderone A, Takahashi N, Yeo K-T, Koren G, Colucci WS and Goldberg MA (1995a) Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 76:758-766.
24. Levy AP, Levy NS, Wegner S and Goldberg MA (1995b) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270: 13333-13340.
25. Levy AP, Levy NS and Goldberg MA (1996) Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271:2746-2753.
26. Li J, Perrella MA, Tsai J-C, Yet S-F, Hsieh C-M, Yoshizumi M, Patterson C, Endege WO, Zhou F and Lee M-E (1995) Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J Biol Chem 270:308-312.
27. Millauer B, Shawver LK, Plate KH, Risau W and Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond) 367:576-579.
28. Nauck M, Roth M, Tamm M, Eickelberg O, Wieland H, Stulz P and Perruchoud AP (1997) Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol 16:398-406.
29. Olah ME and Stiles GL (1995) Adenosine receptor subtypes: Characterization and therapeutic regulation. Ann Rev Pharmacol Toxicol 35:581-606.
30. Pedram A, Razandi J, Hu R-M and Ellis ER (1997) Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 272:17097-17103.
31. 2a selective adenosine receptor antagonist. Br J Pharmacol 115:1096-1102.
32. Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K and Kuwano M (1996) Induction of vascular endothelial growth factor by tumor necrosis factor α in human glioma cells. J Biol Chem 271:28220-28228.
33. 2A-adenosine receptor in primary human endothelial cells. J Biol Chem 272:5792-5799.
34. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML and Schuh AC (1996) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (Lond) 376:62-66.
35. 2-adenosine receptor subtype. Mol Endocrinol 6:384-393.
36. Takagi H, King GL, Robinson GS, Ferrara N and Aiello LP (1996) Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 37:2165-2176.
37. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC and Abraham JA (1991) The human gene for vascular endothelial growth factor. J Biol Chem 266:11947-11954.
38. 2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn-Schmiedeberg's Arch Pharmacol 353:250-260.